The ‘Barbie Drug’—marketing and perceptions of melanotan on social media

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	E. Orr, C. Grechin, N. Kearney, L. Yoo, C. O'Meara, R. Watchorn
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Journal of the European Academy of Dermatology and Venereology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Trending on TikTok: An analysis of melanotan content on social media
di: Maeve Herlihy, et al.
Pubblicazione: (2024)

Reply to ‘EuroGuiderm guideline on lichen sclerosus—Treatment of lichen sclerosus’
di: G. Kravvas, et al.
Pubblicazione: (2025)

Urinary incontinence and female genital lichen sclerosus
di: A. Spencer, et al.
Pubblicazione: (2025)

Anatomical variants of acne differ in their impact on social perception
di: Marek Jankowski, et al.
Pubblicazione: (2024)

Drug utilization among young adults with atopic dermatitis: Influence of sex, socio‐economic status and disease severity
di: P. L. Carmanius, et al.
Pubblicazione: (2024)

Retinoids in the treatment of photoageing: A histological study of topical retinoid efficacy in black skin
di: P. Halai, et al.
Pubblicazione: (2024)

Diving beyond surface perceptions of melanoma diagnosis and screening
di: Efthymia Soura, et al.
Pubblicazione: (2024)

The risk of developing Kaposi sarcoma after a primary malignancy: A surveillance, epidemiology and end results‐based analysis
di: L. Banner, et al.
Pubblicazione: (2024)

Bimekizumab efficacy and safety reaffirmed in Chinese patients, with notable safety findings
di: Yoo Sang Baek, et al.
Pubblicazione: (2026)

Treatment of progressive locally advanced and metastatic basal cell carcinoma after two lines of treatment with hedgehog inhibitors and anti‐PD1: The role of sonidegib rechallenge
di: L. Ambrosio, et al.
Pubblicazione: (2025)

Dermatologists' perception of teledermatology and risk factors for burnout: A cross‐sectional study
di: Tomás Toledo Pastrana, et al.
Pubblicazione: (2025)

Patients' testimonies, feelings, complaints and emotional experiences with dermatoses on open social media: The French infodemiologic patient's free speech study
di: Tom Marty, et al.
Pubblicazione: (2024)

Inclusive by design: Why we must rethink generative AI in dermatology
di: O. E. Dadzie, et al.
Pubblicazione: (2025)

The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use
di: M. E. Jacobson, et al.
Pubblicazione: (2024)

Educational, labour market and relationship outcomes in people with acne
di: John S. Barbieri, et al.
Pubblicazione: (2024)

Efficacy and safety of dupilumab in Hailey–Hailey disease: A multicentre cohort study
di: N. Oillarburu, et al.
Pubblicazione: (2025)

Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group
di: W. Kempf, et al.
Pubblicazione: (2024)

Checkpoint inhibitor‐induced bullous pemphigoid differs from spontaneous bullous pemphigoid
di: N. Kramer, et al.
Pubblicazione: (2024)

KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis – Results from a three‐armed RCT
di: U. Reinhold, et al.
Pubblicazione: (2025)

Skin pain and sleep quality numeric rating scales for children aged 6 months to 5 years with atopic dermatitis
di: A. S. Paller, et al.
Pubblicazione: (2024)

Increased expression of in situ CD123 and reduced Toll‐like receptor 7/9 signalling pathway suggest impaired activation of plasmacytoid dendritic cells in recurrent erythema multiforme
di: N. F. Dias de Oliveira, et al.
Pubblicazione: (2024)

Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients
di: A. E. C. Schirren, et al.
Pubblicazione: (2024)

Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases
di: S. Krämer, et al.
Pubblicazione: (2024)

Drug survival of abrocitinib compared to dupilumab in adult patients with atopic dermatitis
di: Qingjie Hu, et al.
Pubblicazione: (2024)

Drug‐associated hypopigmentation: Disproportionality signals from the French National Database
di: Mohamad Houssam Al Balkhi, et al.
Pubblicazione: (2026)

Drug therapy for extracranial superficial arteriovenous malformation: A systematic review
di: Thomas Hubiche, et al.
Pubblicazione: (2026)

Increasing dosing intervals for biologics in atopic dermatitis‐why, who, when and how?
di: M. E. Jacobson, et al.
Pubblicazione: (2025)

Prevalence of dermatitis including allergic contact dermatitis from medical devices used by children and adults with Type 1 diabetes mellitus: A systematic review and questionnaire study
di: L. B. von Kobyletzki, et al.
Pubblicazione: (2024)

Impact of dermoscopy training associated with artificial intelligence on general practitioner residents
di: C. Dorado Cortez, et al.
Pubblicazione: (2024)

Out‐of‐pocket expenses of hidradenitis suppurativa: A cross‐sectional study
di: M. Delage‐Toriel, et al.
Pubblicazione: (2025)

Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study
di: Yunyun Miao, et al.
Pubblicazione: (2025)

Tangential biopsy of the nail bed and matrix, with plate evaluation, for diagnosis of lichen planus
di: L. Bertanha, et al.
Pubblicazione: (2024)

Melanocytic clefting is associated with melanoma on LC ‐ OCT
di: J. Pérez‐Anker, et al.
Pubblicazione: (2025)

Criteria for melanocytic lesions in LC‐OCT
di: J. Perez‐Anker, et al.
Pubblicazione: (2024)

Efficacy and safety of tozorakimab in moderate‐to‐severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER‐2)
di: J. I. Silverberg, et al.
Pubblicazione: (2024)

Difficulties in diagnosing dermatophytomas: Analysis of clinical and dermoscopic findings
di: Rhiannon C. Miller, et al.
Pubblicazione: (2024)

Public‐health implications of market drug withdrawals: A focus on antifungals for tinea capitis
di: Annabel Maruani, et al.
Pubblicazione: (2025)

Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study
di: N. Omari, et al.
Pubblicazione: (2024)

Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management
di: F. Tetart, et al.
Pubblicazione: (2024)

Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real‐world retrospective study from Spain and systematic review of the published data
di: J. Cañueto, et al.
Pubblicazione: (2024)